141 related articles for article (PubMed ID: 1472100)
1. Inhibition of proliferation of human leukaemia 60 cells by diethyl esters of glyoxalase inhibitors in vitro.
Lo TW; Thornalley PJ
Biochem Pharmacol; 1992 Dec; 44(12):2357-63. PubMed ID: 1472100
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of growth of human leukaemia 60 cells by S-2-hydroxyacylglutathiones and monoethyl ester derivatives.
Clelland JD; Allen RE; Thornalley PJ
Biochem Pharmacol; 1992 Nov; 44(10):1953-9. PubMed ID: 1449514
[TBL] [Abstract][Full Text] [Related]
3. S-fluorenylmethoxycarbonyl glutathione and diesters: inhibition of mammalian glyoxalase II.
Chyan MK; Elia AC; Principato GB; Giovannini E; Rosi G; Norton SJ
Enzyme Protein; 1994-1995; 48(3):164-73. PubMed ID: 8589803
[TBL] [Abstract][Full Text] [Related]
4. Antimalarial activity in vitro of the glyoxalase I inhibitor diester, S-p-bromobenzylglutathione diethyl ester.
Thornalley PJ; Strath M; Wilson RJ
Biochem Pharmacol; 1994 Jan; 47(2):418-20. PubMed ID: 8304987
[TBL] [Abstract][Full Text] [Related]
5. N,S-bis-fluorenylmethoxycarbonylglutathione: a new, very potent inhibitor of mammalian glyoxalase II.
Elia AC; Chyan MK; Principato GB; Giovannini E; Rosi G; Norton SJ
Biochem Mol Biol Int; 1995 Apr; 35(4):763-71. PubMed ID: 7627127
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human leukaemia 60 cell growth by diethyl esterification of the glyoxalase II inhibitor S-p-nitrobenzoxycarbonylglutathione in vitro.
Lo TW; Thornalley PJ
Biochem Soc Trans; 1993 May; 21(2):159S. PubMed ID: 8359412
[No Abstract] [Full Text] [Related]
7. Antitumour activity of S-p-bromobenzylglutathione cyclopentyl diester in vitro and in vivo. Inhibition of glyoxalase I and induction of apoptosis.
Thornalley PJ; Edwards LG; Kang Y; Wyatt C; Davies N; Ladan MJ; Double J
Biochem Pharmacol; 1996 May; 51(10):1365-72. PubMed ID: 8787553
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis and Biological Evaluation of Potent Human Glyoxalase I Inhibitors.
Jin T; Zhai J; Liu X; Yue Y; Huang M; Li Z; Ni C; Deng Q; Sang Y; Yao Z; Zhang H; Hu X; Zheng ZB
Chem Pharm Bull (Tokyo); 2017 May; 65(5):455-460. PubMed ID: 28320998
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of glyoxalase I by the enediol mimic S-(N-hydroxy-N-methylcarbamoyl)glutathione. The possible basis of a tumor-selective anticancer strategy.
Hamilton DS; Creighton DJ
J Biol Chem; 1992 Dec; 267(35):24933-6. PubMed ID: 1459997
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of proliferation of human promyelocytic leukaemia HL60 cells by S-D-lactoylglutathione in vitro.
Thornalley PJ; Tisdale MJ
Leuk Res; 1988; 12(11-12):897-904. PubMed ID: 2905755
[TBL] [Abstract][Full Text] [Related]
11. A new method for rapidly generating inhibitors of glyoxalase I inside tumor cells using S-(N-aryl-N-hydroxycarbamoyl)ethylsulfoxides.
Hamilton DS; Kavarana MJ; Sharkey EM; Eiseman JL; Creighton DJ
J Med Chem; 1999 May; 42(10):1823-7. PubMed ID: 10346934
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of S-(p-bromobenzyl)glutathione diesters in vitro: a structure-activity study.
Thornalley PJ; Ladan MJ; Ridgway SJ; Kang Y
J Med Chem; 1996 Aug; 39(17):3409-11. PubMed ID: 8765525
[TBL] [Abstract][Full Text] [Related]
13. Small molecule probes of glyoxalase I and glyoxalase II.
Barnard JF; Vander Jagt DL; Honek JF
Biochim Biophys Acta; 1994 Sep; 1208(1):127-35. PubMed ID: 8086426
[TBL] [Abstract][Full Text] [Related]
14. Advances in glyoxalase research. Glyoxalase expression in malignancy, anti-proliferative effects of methylglyoxal, glyoxalase I inhibitor diesters and S-D-lactoylglutathione, and methylglyoxal-modified protein binding and endocytosis by the advanced glycation endproduct receptor.
Thornalley PJ
Crit Rev Oncol Hematol; 1995 Aug; 20(1-2):99-128. PubMed ID: 7576201
[No Abstract] [Full Text] [Related]
15. S-(N-aryl-N-hydroxycarbamoyl)glutathione derivatives are tight-binding inhibitors of glyoxalase I and slow substrates for glyoxalase II.
Murthy NS; Bakeris T; Kavarana MJ; Hamilton DS; Lan Y; Creighton DJ
J Med Chem; 1994 Jul; 37(14):2161-6. PubMed ID: 8035422
[TBL] [Abstract][Full Text] [Related]
16. A simplified method for the purification of human red blood cell glyoxalase. I. Characteristics, immunoblotting, and inhibitor studies.
Allen RE; Lo TW; Thornalley PJ
J Protein Chem; 1993 Apr; 12(2):111-9. PubMed ID: 8489699
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of mammalian glyoxalase I (lactoylglutathione lyase) by N-acylated S-blocked glutathione derivatives as a probe for the role of the N-site of glutathione in glyoxalase I mechanism.
Al-Timari A; Douglas KT
Biochim Biophys Acta; 1986 Mar; 870(1):160-8. PubMed ID: 3947646
[TBL] [Abstract][Full Text] [Related]
18. Bivalent transition-state analogue inhibitors of human glyoxalase I.
Zheng ZB; Creighton DJ
Org Lett; 2003 Dec; 5(25):4855-8. PubMed ID: 14653691
[TBL] [Abstract][Full Text] [Related]
19. Mechanism-based competitive inhibitors of glyoxalase I: intracellular delivery, in vitro antitumor activities, and stabilities in human serum and mouse serum.
Kavarana MJ; Kovaleva EG; Creighton DJ; Wollman MB; Eiseman JL
J Med Chem; 1999 Jan; 42(2):221-8. PubMed ID: 9925727
[TBL] [Abstract][Full Text] [Related]
20. The human glutathione transferase P1-1 specific inhibitor TER 117 designed for overcoming cytostatic-drug resistance is also a strong inhibitor of glyoxalase I.
Johansson AS; Ridderström M; Mannervik B
Mol Pharmacol; 2000 Mar; 57(3):619-24. PubMed ID: 10692504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
